Fenimore Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Fenimore Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,740	Closed	-$81K	–	115
2021 Q2	$81K	Sell	2,740 -500	-15%	-$13.9K	﹤0.01%	124
2021 Q1	$102K	Hold	3,240	–	–	﹤0.01%	118
2020 Q4	$86K	Hold	3,240	–	–	﹤0.01%	111
2020 Q3	$87K	Hold	3,240	–	–	﹤0.01%	106
2020 Q2	$64K	Hold	3,240	–	–	﹤0.01%	106
2020 Q1	$49K	Hold	3,240	–	–	﹤0.01%	111
2019 Q4	$56K	Hold	3,240	–	–	﹤0.01%	114
2019 Q3	$81K	Hold	3,240	–	–	﹤0.01%	118
2019 Q2	$98K	Sell	3,240 -2,760	-46%	-$108K	﹤0.01%	119
2019 Q1	$172K	Sell	6,000 -4,000	-40%	-$128K	0.01%	114
2018 Q4	$182K	Buy	+10,000	New	+$238K	0.01%	116

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Fenimore Asset Management's CKPT Position: Q3 2021 in Review

Fenimore Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q3 2021, closing a stake of 2,740 shares — an estimated $81K sold.

Fenimore Asset Management first reported a position in CKPT in Q4 2018 and held it in 11 quarters. The position peaked at $182K in Q4 2018. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

Fenimore Asset Management reported no remaining Checkpoint Therapeutics position as of Q3 2021 after selling out during the quarter.
Fenimore Asset Management sold 2,740 Checkpoint Therapeutics shares in Q3 2021, an estimated $81K.
Fenimore Asset Management first reported a position in Checkpoint Therapeutics in Q4 2018 and held it in 11 quarters.
Fenimore Asset Management's Checkpoint Therapeutics position peaked at $182K in Q4 2018.
67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Fenimore Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.